PROTECT-CH was designed as a UK-wide platform clinical trial to evaluate prophylactic treatments for COVID-19 in care home residents.
Due to the success of the UK COVID-19 vaccination programme, and other measures taken by care homes to reduce the spread of COVID-19, it became clear that the study would require many times more care homes and residents to evaluate prophylactic treatments than was assumed when designing the study.